#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Piriformis syndrome Spinal muscular atrophy Hypergammaglobulinaemia benign monoclonal Bronchopulmonary aspergillosis Mantle cell lymphoma refractory Neuroendocrine carcinoma metastatic Chronic myeloid leukaemia (in remission) Osteosarcoma metastatic Fibrodysplasia ossificans progressiva Malformation venous Autoimmune disorder Hodgkin's disease recurrent Dupuytren's contracture B-cell lymphoma refractory Fibrous dysplasia of bone More trials…

    Learn about Rare Diseases

    Andersen-Tawil syndrome Acquired haemophilia – Trials in Disease Testicular leiomyosarcoma – Trials in Disease Mitochondrial myopathy – Diagnostics Factor IX deficiency – Basic Information Paraneoplastic neurological syndrome Richter’s syndrome – Diagnostics Pleomorphic leiomyosarcoma – Treatment Gastrointestinal stromal tumour Gastrointestinal stromal tumour – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Zolbetuximab Potato Starch Vanglusagene Ensiparvovec Edotreotide Valsartan Amphotericin B Risankizumab Vinflunine Nomegestrol Acetate Talazoparib Haloperidol Decanoate Indacaterol Acetate Sar441566 Letetresgene Autoleucel Mirvetuximab Soravtansine Pralatrexate [18F]DED Sodium Ponatinib Nms-03592088 More therapies…

    Learn about Your Condition

    Biliary cancer metastatic Dermatitis atopic End stage renal disease Lymphangioleiomyomatosis Insulin resistance Haemofiltration Haemorrhage intracranial Post procedural infection Vertigo Prostatitis Escherichia coli Transplant rejection Primary biliary cholangitis Fibromyalgia Cardiac disorder Tympanic membrane perforation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute myeloid leukaemia

  • Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

    Recruiting

    2 1 1
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    Austria Bulgaria Germany Hungary Poland Romania +2

  • Study of Monalizumab for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Haploidentical Transplantation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Monalizumab
    Italy

  • Study on Midostaurin and Gemtuzumab Ozogamicin for Adults with Acute Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Midostaurin
    • Cytarabine
    Germany

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Fludarabine Phosphate
    • Cytarabine
    • Daunorubicin
    Belgium Denmark Finland The Netherlands Norway Spain +1

  • Study on Fludarabine, Melphalan, and Radiation for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Preparing for Stem Cell Transplant.

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Melphalan
    • Fludarabine Phosphate
    • Cyclophosphamide
    Spain

  • Study on Cyclophosphamide and Etoposide with Radiation for High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Patients Preparing for Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cyclophosphamide
    • Etoposide
    • Mycophenolate Mofetil
    Spain
Previous Page
1 … 4 5 6 7 8 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!